Studies suggest new breast screening standards | MassDevice.com On Call
May 1, 2012 by MassDevice staff
A pair of studies suggests that women with relatives who have breast cancer or who have dense breast tissue should begin having mammograms every 2 years at age 40, helping settle the uncertainty over how often women should be screened for breast cancer.
MASSDEVICE ON CALL — Two studies published today in the Annals of Internal Medicine could influence the standard of care for breast screening, which was called into question by a U.S. Preventive Services Task Force report in 2009.
That report suggested that annual mammograms might cause more harm than good because of increased false positives leading to unnecessary biopsies and further testing – not to mention considerable anxiety for patients.
- Show full page
- Login to post comments
-
Permalink
RECENT BLOG POSTS
- Is Valeant About To Make A Bold Bid For Bausch & Lomb?
- When regulators are ignored
- FDA Issues Draft Guidance to Help Companies Distinguish Between a Voluntary Medical Device Recall and a Product Enhancement
- Patient and family engagement in ICUs
- A day in the life: A pediatric neurosurgeon's vision
- Medical Device Tax: Are Conservatives' goals hampering repeal efforts?
- Personal health record use by adolescents
- Can Johnson & Johnson fire on all cylinders again?
- U.S. FDA to require proof of IEC 60601-1 3rd Edition in summer 2013
- A cure for coffee breath?
Navigation
NEWS
Uroplasty touts positive 3-year outcomes for neurostimulation in treatment of overactive bladder
Covidien’s 3-year study results showing positive outcomes for its Urgent PC Neuromodulation system in...
FDA clears 21-inch medical monitors from NEC Display Solutions
NEC Display Solutions wins 510(k) clearance for its 21-inch medical monitor systems.
Johnson and Johnson executive splits for the corner office at Itamar Medical | Personnel Moves
J&J's former head of global cardiology makes the jump to CEO at Itamar Medical
Sunshine Heart seeks $25.5M in equity funding round | Wall Street Beat
Sunshine Heart raises $1.5 million of a hoped-for $25.5 million equity funding round.
J&J sues Shasta Technologies for logo infringement
J&J subsidiary Lifescan asks the courts to ban Shasta from using its logo, saying problems with...
